A 10-year study has determined that annual CT scans could prevent as many as half of lung cancer deaths. Annual screening detects early-stage lung cancers, which have a curability rate of 80% to 90%.
A 10-year study has determined that annual CT scans could prevent as many as half of lung cancer deaths. Annual screening detects early-stage lung cancers, which have a curability rate of 80% to 90%.
"More than 80% of the diagnosed lung cancer we found in initial and annual repeat CT screenings were stage I, the most curable form of lung cancer," said Dr. Claudia I. Henschke, principal investigator and division chief of chest imaging at New York Hospital-Cornell Medical Center.
An international study of 2968 high-risk patients conducted by the Early Lung Cancer Action Project found that annual screens are most likely to catch lung cancer at its earliest stages. Lung cancer symptoms often do not appear until the cancer has advanced to stage II or III.
The ELCAP study found that people with part-solid lung nodules were 19 times more likely to develop cancer than those with completely solid nodules. In addition, at-risk women are 2.2 times more likely to develop cancer than at-risk men.
"There is, as of yet, no clear consensus why women are at increased risk," Henschke said.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.